XML 37 R27.htm IDEA: XBRL DOCUMENT v3.23.3
Net Income (Loss) Per Share Attributable to Common Stockholders (Tables)
9 Months Ended
Sep. 30, 2023
Earnings Per Share [Abstract]  
Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders
The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders (in thousands, except share and per share data):
Three Months Ended
September 30,
Nine Months Ended
September 30,
Basic net income (loss) per share:
2023202220232022
Numerator:
Net Income (loss) attributable to common stockholders
$1,525 $(79,206)$(397,947)$(191,099)
Denominator:
Basic weighted-average shares outstanding
672,559,810 583,970,409 638,388,011 581,458,391 
Basic net income (loss) per share attributable to common stockholders
$0.00 $(0.14)$(0.62)$(0.33)
Diluted net income (loss) per share:
Numerator
Net Income (loss) attributable to common stockholders
$1,525 $(79,206)$(397,947)$(191,099)
Less:
Income attributable to participating securities(1)
$(46)— — — 
Diluted net income (loss) attributable to common stockholders1,479 (79,206)(397,947)(191,099)
Denominator:
Number of shares used in basic net income (loss) per share computation672,559,810 — 583,970,409 — 638,388,011 — 581,458,391 
Weighted-average dilutive securities18,895,352 — — — — 
Diluted weighted-average common stock outstanding691,455,162 583,970,409 638,388,011 581,458,391 
Diluted net income (loss) per share attributable to common stockholders$0.00 $(0.14)$(0.62)$(0.33)
(1) Participating securities include Earnout shares, unvested early exercised options and unvested restricted stock awards.
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The following outstanding shares of potentially dilutive securities were excluded from the computation of diluted net income (loss) per share attributable to common stockholders for the periods presented because including them would have been antidilutive:
Three Months Ended
September 30,
Nine Months Ended
September 30,
20232023
Common stock warrants28,783,333 28,783,333 
Unvested restricted stock units3,596,979 29,342,561 
Options to purchase common stock and unvested restricted stock awards3,959,867 18,216,147 
ESPP— 1,042,062 
Total36,340,179 77,384,103 
Three and Nine Months Ended September 30, 2022
Common stock warrants28,783,333 
Unvested restricted stock units23,201,266 
Options to purchase common stock and unvested restricted stock awards25,145,381 
Earnout Shares17,130,000 
Total94,259,980